
Tirzepatide 30mg supplied as a lyophilised laboratory research material. UK-based stock with batch traceability and independent analytical testing programme. Research use only.
In stock
Tirzepatide is a synthetic peptide studied in laboratory research as a dual agonist of GIP and GLP-1 receptor signalling. Research examines receptor pharmacology, downstream cellular signalling and mechanisms associated with metabolic regulation. VOREVIA supplies this material strictly for laboratory research and analytical investigation. It is not for human consumption, therapeutic, diagnostic or veterinary use.